---
title: "300006.SZ (300006.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300006.SZ/news.md"
symbol: "300006.SZ"
name: "300006.SZ"
parent: "https://longbridge.com/en/quote/300006.SZ.md"
datetime: "2026-05-21T17:41:32.057Z"
locales:
  - [en](https://longbridge.com/en/quote/300006.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300006.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300006.SZ/news.md)
---

# 300006.SZ (300006.SZ) — Related News

### [Zhongheng Group: The holding subsidiary has received the approval notice for the listing application of chemical raw materials](https://longbridge.com/en/news/286543788.md)
*2026-05-15T10:05:11.000Z*
> Zhongheng Group Holdings' subsidiary Chongqing Lummy Longyu Pharmaceutical has received the approval notice for the list

### [Lummy released its first-quarter performance, with a net loss attributable to the parent company of 15.0127 million yuan](https://longbridge.com/en/news/283685565.md)
*2026-04-22T14:31:29.000Z*
> Lummy released its first quarter report for 2026, with operating revenue of 182 million yuan, a year-on-year decrease of

### [[A-Share Midday Review] The ChiNext Index surged and then fell, down 0.46%, with the chemical sector collectively strengthening](https://longbridge.com/en/news/281841317.md)
*2026-04-07T07:10:24.000Z*
> On April 7th, the three major indices of A-shares surged and then retreated, with the ChiNext Index falling by 0.46%. Th

### [Lummy's stock price fluctuation: A loss of 135 million yuan in 2025, with no significant changes in operational conditions and internal and external business environment](https://longbridge.com/en/news/281634413.md)
*2026-04-03T11:49:14.000Z*
> Lummy issued an announcement on abnormal fluctuations due to its stock price deviating by 30% for three consecutive days

### [Sansure Biotech, Chemexpress and others establish new venture capital funds](https://longbridge.com/en/news/280938685.md)
*2026-03-30T01:52:19.000Z*
> According to the Qichacha APP, recently, Guangzhou Shengquan Baijie Venture Capital Fund Partnership was established wit

### [Lummy Pharmaceutical faces losses again, and the combination of generics and innovation cannot conceal the difficulties of transformation](https://longbridge.com/en/news/280563062.md)
*2026-03-26T03:55:13.000Z*
> Lummy recently released its annual report for 2025, with total operating revenue of 776 million yuan, a year-on-year dec

### [Lummy: Supplementary application for injectable Amikacin approved](https://longbridge.com/en/news/280275365.md)
*2026-03-24T07:46:30.000Z*
> Lummy announced that it recently received the "Drug Supplement Application Approval Notice" issued by the National Medic

### [Lummy released its 2025 annual performance, with a net loss attributable to the parent company of 135 million yuan](https://longbridge.com/en/news/279591308.md)
*2026-03-18T11:53:14.000Z*
> Lummy released its annual report for 2025, with operating revenue of 776 million yuan, a year-on-year decrease of 2.50%.

### [Zhongheng Group's holding subsidiary plans to invest 5 million yuan to participate in the establishment of a venture capital fund](https://longbridge.com/en/news/278858986.md)
*2026-03-12T09:58:03.000Z*
> Zhongheng Group's holding subsidiary Lummy has signed partnership agreements with multiple institutions to jointly estab